Percentage of high‐grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score

作者: Jens Hansen , Marco Bianchi , Maxine Sun , Michael Rink , Fabio Castiglione

DOI: 10.1111/BJU.12424

关键词: Gleason grading systemBiochemical recurrenceInternal medicineProspective cohort studyRegression analysisProportional hazards modelProstate cancerMedicineCohort studyGynecologyProstatectomyOncology

摘要: Objective To examine whether percentage of tumour volume (%TV) and high-grade (%HGTV) help to better identify men at higher risk early biochemical recurrence (BCR) after radical prostatectomy (RP) for non-metastatic high-risk prostate cancer, as BCR RP might be associated with metastases cancer-specific mortality. Patients Methods We examined the data 595 treated cancer between 1992 2011 two European tertiary care centres. Kaplan–Meier analyses were used graphically depict 2-year BCR-free survival. Multivariable Cox regression models addressed BCR. We tested addition %TV %HGTV a multivariable model helps increase model's predictive accuracy (PA) prediction BCR. Results In all, 32 (10%) specimen-confined (pT2–pT3a, negative surgical margin, pN0) 67 (24%) non-specimen-confined had BCR. After stratification according (%HGTV threshold: ≤33.33 vs >33.33%), survival rates respectively 93 60% (log-rank P < 0.001). In emerged an independent predictor (P 0.05). However, adding (regardless its coding) other covariates in analysis did not PA meaningful fashion compared use detailed Gleason grading system (6 7a 7b 8 9–10). Conclusions In large cohort patients improve substantially, although was BCR. Therefore, sophisticated TV/HGTV measurements do seem have additional benefit relative grading. However, these results need confirmed larger, prospective studies.

参考文章(30)
Gleason Df, Classification of prostatic carcinomas. Cancer chemotherapy reports. ,vol. 50, pp. 125- 128 ,(1966)
Lars Budäus, Jan Spethmann, Hendrik Isbarn, Jan Schmitges, Laura Beesch, Alexander Haese, Georg Salomon, Thorsten Schlomm, Margit Fisch, Hans Heinzer, Hartwig Huland, Markus Graefen, Thomas Steuber, Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade BJUI. ,vol. 108, pp. 1256- 1261 ,(2011) , 10.1111/J.1464-410X.2010.09982.X
Michael Froehner, Rainer Koch, Rainer J. Litz, Oliver W. Hakenberg, Manfred P. Wirth, Which patients are at the highest risk of dying from competing causes ≤10 years after radical prostatectomy? BJUI. ,vol. 110, pp. 206- 210 ,(2012) , 10.1111/J.1464-410X.2011.10693.X
Thomas A. Stamey, Fuad S. Freiha, John E. McNeal, Elise A. Redwine, Alice S. Whittemore, Hans-Peter Schmid, Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer Cancer. ,vol. 71, pp. 933- 938 ,(1993) , 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L
Axel Heidenreich, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Malcolm Mason, Vsevolod Matveev, Nicolas Mottet, Hans-Peter Schmid, Theo van der Kwast, Thomas Wiegel, Filliberto Zattoni, EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. European Urology. ,vol. 59, pp. 61- 71 ,(2011) , 10.1016/J.EURURO.2010.10.039
Jochen Walz, Felix K.-H. Chun, Eric A. Klein, Alwyn Reuther, Fred Saad, Markus Graefen, Hartwig Huland, Pierre I. Karakiewicz, Nomogram Predicting the Probability of Early Recurrence After Radical Prostatectomy for Prostate Cancer The Journal of Urology. ,vol. 181, pp. 601- 608 ,(2009) , 10.1016/J.JURO.2008.10.033
CHRISTIAN G. RAMOS, KIMBERLY A. ROEHL, JO ANN V. ANTENOR, PETER A. HUMPHREY, WILLIAM J. CATALONA, PERCENT CARCINOMA IN PROSTATECTOMY SPECIMEN IS ASSOCIATED WITH RISK OF RECURRENCE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICALLY ORGAN CONFINED PROSTATE CANCER The Journal of Urology. ,vol. 172, pp. 137- 140 ,(2004) , 10.1097/01.JU.0000132139.40964.75
EIJI KIKUCHI, PETER T. SCARDINO, THOMAS M. WHEELER, KEVIN M. SLAWIN, MAKOTO OHORI, Is tumor volume an independent prognostic factor in clinically localized prostate cancer The Journal of Urology. ,vol. 172, pp. 508- 511 ,(2004) , 10.1097/01.JU.0000130481.04082.1A
MAXWELL V. MENG, ERIC P. ELKIN, DAVID M. LATINI, JANEEN DuCHANE, PETER R. CARROLL, TREATMENT OF PATIENTS WITH HIGH RISK LOCALIZED PROSTATE CANCER: RESULTS FROM CANCER OF THE PROSTATE STRATEGIC UROLOGICAL RESEARCH ENDEAVOR (CaPSURE) The Journal of Urology. ,vol. 173, pp. 1557- 1561 ,(2005) , 10.1097/01.JU.0000154610.81916.81
Benjamin I. Chung, Tatum V. Tarin, Michelle Ferrari, James D. Brooks, Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival Urologic Oncology: Seminars and Original Investigations. ,vol. 29, pp. 314- 318 ,(2011) , 10.1016/J.UROLONC.2009.06.017